Abstract
7.1
Chronic relapsing idiopathic inflammation of the rectum and variable length of the adjoining colon.
7.2
• Crohn’s disease is a chronic inflammation which initially was believed to be located to the terminal ileum. However, it is now well known that it may involve any part of the gastrointestinal tract from mouth to anus.
• Characteristic is its segmental distribution, often with rectal sparing but frequently with anorectal disease.
• The onset is common in young people and the burden to the healthcare system as well as the community is substantial.
• Until now there is no cure for Crohn’s disease and both the medical and surgical treatment aims at reducing the symptom load.
• Many patients can live a fairly normal life but 20–30% have more or less severe restrictions of their working ability.
• The cumulative mortality has been increased, approximately twofold.
• Sepsis, liver failure and thromboembolism are the main causes of death in patients with severe chronic disease.
7.3
The term “indeterminate colitis” was first introduced by Ashley Price, a pathologist at St. Mark’s Hospital in London, UK. He used it to describe colectomy specimens where a definite diagnosis of ulcerative colitis or Crohn’s disease could not be established due to overlapping features. At the time it was felt that indeterminate colitis was likely to represent a temporary state in the evolution of inflammatory bowel disease, which in due course would declare itself as either ulcerative colitis or Crohn’s disease.
7.4
Colorectal diverticular disease and its complications are highly prevalent conditions in daily practice in Western countries. Different etiological factors have been involved, although none of them can explain by itself the development of colonic diverticular disease. Diverticular disease of the colon is usually an asymptomatic disease. In symptomatic patients, treatment with new drugs may reduce abdominal symptoms and even the incidence of diverticulitis. Diverticulitis is the most frequent complication of colonic diverticular disease. Clinical manifestations, diagnostic procedures, complications and treatment strategies are described. The efficacy of mesalazine in improving the severity of symptoms and in preventing symptomatic recurrence of diverticulitis is emphasized. Elective surgical treatment of diverticular disease is usually considered when a fistula or symptomatic stenosis has developed. However, after a first episode of complicated diverticulitis with an abscess successfully resolved by percutaneous drainage, surgical treatment is controversial. Elective surgical procedures should only rarely be offered to patients who have presented two episodes of uncomplicated diverticulitis. Basic principles of the surgical technique are described. The management of diverticular disease in young patients has changed in recent years but this issue continue to be a matter of debate.
7.5
Necrotising enterocolitis (NEC) represents a significant clinical problem. Ischaemic and necrotic alterations in the intestinal wall more frequently refer to the terminal ileum than to the caecum and ascending colon. The necrosis begins in the mucous layer and then may involve the full thickness of the bowel wall resulting in perforation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Chapter 7.2
Andersson P, Olaison G, Hallböök O, Sjödahl R (2002) Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 45:47–53
Andersson P, Olaison G, Bentsen P, Myrelid P, Sjödahl R (2003) Health-related quality of life in Crohn’s proctocolitis does not differ from the general population when in remission. Colorectal Dis 5:56–62
Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231:38–45
Best WR (2006) Predicting the Crohn’s disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 12:304–310
Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23:1097–1104
Cosnes J, Beaugerie L, Carbonnel F, Gendre JP (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120:1093–1099
D’Haens G, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P (1998) Early lesions of recurrent Crohn’s disease caused by infusion of gastrointestinal contents in excluded ileum. Gastroenterology 114:262–267
D’Haens G, Geboes K, Rutgeerts P (1999) Endoscopic and histologic healing of Crohn’s (ileo-) colitis with azathioprine. Gastrointest Endosc 50:667–671
Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ (2005) Perianal Crohn’s disease: predictors of need for permanent diversion. Ann Surg 241:796–802
Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ Sutherland LR (1998) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna
Gaya DR, Russell RK, Nimmo ER, Satsangi J (2006) New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 367:1271–1284
Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MR (2001) Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum 44:20–26
Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G (1984) Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut 25:665–672
Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB (2006) Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease. Gastrointest Endosc 63:433–442
Chapter 7.3
Burakoff R (2004) Indeterminate colitis: clinical spectrum of disease. J Clin Gastroenterol 38:S41–S43
Gramlich T, Delaney CP, Lynch AC, Remzi FH, Fazio VW (2003) Pathological subgroups may predict complications but not late failure after ileal pouch–anal anastomosis for indeterminate colitis. Colorectal Dis 5:315–319
Guindi M, Riddell RH (2004) Indeterminate colitis. J Clin Pathol 57:1233–1244
Odze RD (2004) Pathology of indeterminate colitis. J Clin Gastroenterol 38:S36–S40
Price AB (1978) Overlap in the spectrum of non-specific inflammatory bowel disease: colitis indeterminate. J Clin Pathol 31:567–577
Chapter 7.4
Ambrosetti P, Chautems R, Soravia C, Peiris-Waser N, Terrier F (2005) Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases. Dis Colon Rectum 48:787–791
Broderick-Villa G, Burchette RJ, Collins JC, Abbas MA, Haigh PI (2005) Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg 140:576–581
Chapman JR, Dozois EJ, Wolff BG, Gullerud RE, Larson DR (2006) Diverticulitis: a progressive disease? Do multiple recurrences predict less favorable outcomes? Ann Surg 243:876–880
Comparato G, Fanigliolo L, Cavallaro LG, Aragona G, Cabestro GM, Iori V et al (2007) Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci 52:2934–2941
Janes S, Meagher A, Frizelle FA (2005) Elective surgery after acute diverticulitis. Br J Surg 92:133–142
Nelson RS, Velasco A, Mukesh DN (2006) Management of diverticulitis in younger patients. Dis Colon Rectum 49:1341–1345
Purkayastha S, Constantinides VA, Tekkis PP, Athanasiou T, Aziz A, Tilney H et al (2006) Laparoscopic vs. open surgery for diverticular disease: a meta-analysis of nonrandomized studies. Dis Colon Rectum 49:446–463
Rafferty J, Shellito P, Hyman, NH, Buie WD (2006) Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 49:939–944
Salem TA, Molloy RG, O’Dwyer PJ (2007) Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease. Dis Colon Rectum 50:1460–1464
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Conaghan, P. et al. (2008). Inflammatory Bowel Disease. In: Herold, A., Lehur, PA., Matzel, K., O'Connell, P. (eds) Coloproctology. European Manual of Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71217-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-71217-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71216-9
Online ISBN: 978-3-540-71217-6
eBook Packages: MedicineMedicine (R0)